Itch in primary biliary cirrhosis: A patients' perspective

Acta Dermato-Venereologica

Volumn 88, Issue 1, 2008, Pages 34-37

  Rishe, Eric ^a   Azarm, Ali ^b   Bergasa, Nora V ^c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b KINGS COUNTY HOSPITAL CENTER   (United States)

^c WOODHULL MEDICAL CENTER   (United States)

Author keywords

Itch; Primary biliary cirrhosis

Indexed keywords

ANTIHISTAMINIC AGENT; COLESTYRAMINE;

ARTICLE; BILIARY CIRRHOSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; QUESTIONNAIRE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ANTIPRURITICS; FEMALE; HUMANS; INTERNET; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PARESTHESIA; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; PRURITUS; QUESTIONNAIRES; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 38549165285     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0350     Document Type: Article

References (18)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273.
2. Heathcote J. The clinical expression of primary biliary cirrhosis. Semin Liver Dis 1997; 17: 23-33.
3. Elias E, Burra P. Primary biliary cirrhosis: symptomatic treatment. J Gastroenterol Hepatol 1991; 6: 570-573.
4. Elias E. Liver transplantation. J Roy Coll Phys London 1993; 27: 224-232.
5. Neuberger J, Jones EA. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy. Eur J Gastroenterol Hepatol 2001; 13: 1393-1394.
6. Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Schmitt JM, et al. Naloxone ameliorates the pruritus of cholestasis: results of a double-blind randomized placebo-controlled trial. Ann Int Med 1995; 123: 161-167.
7. Wolfhagen FHJ, Sternieri E, Hop WCJ, Vitale G, Bertolotti M, van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997; 113: 1264-1269.
8. Bergasa NV, Alling DW, Talbot TL, Wells M, Jones EA. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 1999; 41: 431-434.
9. Bergasa NV, Link MJ, Keogh M, Yaroslavsky G, Rosenthal RN, McGee M. Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease. Am J Gastroenterol 2001; 96: 1563-1570.
10. Pares A, Cisneros L, Salmeron JM, Caballeria L, Mas A, Torras A, Rodes J. Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2004; 99: 1105-1110.
11. Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology 2007; 45: 666-674.
12. Talbot TL, Schmitt JM, Bergasa NV, Jones EA, Walker EC. Application of piezo film technology for the quantitative assessment of pruritus. Biomed Instrument Technol 1991; 25: 400-403.
13. Babe KS, Serfin WE. Histamin, bradykinin and their antagonists. In: Hardman JG, Limbrid LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. New York: McGraw-Hill, 1996: p. 581-600.
14. Mitchison HC, Bassendine MF, Malcolm AJ, Watson AJ, Record CO, James OF. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology 1989; 10: 420-429.
15. Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992; 102: 544-549.
16. Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Turner ML, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med 1995; 123: 161-167.
17. Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, et al. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 1998; 27: 679-684.
18. Floreani A, Carderi I, Variola A, Rizzotto ER, Nicol J, Bergasa NV. A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus. Hepatology 2006; 43: 1152-1154.